Preclinical evidence associates anxiety with amyloid pathology in older adults, suggesting different pathways for anxiety and depression.
Preclinical amyloid pathology directly associates with subclinical anxiety but only indirectly with depression through subjective stress, suggesting distinct neuropsychiatric pathways in early AD that could inform detection strategies.
No takes yet. Share an insight, caveat, or question.
Vogelgsang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: